The Latest Data on Lipid-Lowering Therapies for ASCVD and What it Means for Practicing Clinicians

The Latest Data on Lipid-Lowering Therapies f...

Up next

Beyond Intervals: The Next Era of Continuous Delivery in Retinal Medicine

Are you up to date on developments in technology for treating retinovascular disease? Credit available for this activity expires: 7/24/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/beyond-intervals-next-era-continuous-delivery-retinal-20 ...  Show more

When and How Should I Optimize Heart Failure Treatments for My Patients?

Gain expert insights on how best to implement GDMT for your patients in the transition from hospitalization to post-discharge. Credit available for this activity expires: 7/22/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/when-and-how-sh ...  Show more

Recommended Episodes

#361 Advanced Lipidology
The Curbsiders Internal Medicine Podcast

Lipids Update 2022: Cardiovascular Risk Reduction and New Medications on the Horizon with Erin Michos, MDShow description: Ready to take the next step in management of your patient with hyperlipidemia? Dr. Erin Michos (@erinmichos) returns to give us a lesson in Advanced Lipidolo ...  Show more

Recent Clinical Advances in Reducing Risk for Dyslipidemia
Medscape InDiscussion: Dyslipidemia

In this episode, host Dr. Laurence Sperling speaks with Drs Erin Michos and Peter Toth about optimal use of newer dyslipidemia therapies. Relevant disclosures can be found with the episode show notes on Medscape.com ( https://www.medscape.com/viewarticle/958749). The topics and di ...  Show more

Decoding Hyperlipidemia Management: What Does the Evidence Say? - Frankly Speaking Ep 332
Frankly Speaking About Family Medicine

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-332

Overview: In this episode, w ...

  Show more

Novel Lipid-Lowering Therapies to Reduce Cardiovascular Risk
JAMA Clinical Reviews

Several new therapeutic drug classes are now available to manage lipid levels. John Wilkins, MD, MS, and Donald Lloyd-Jones, MD, ScM, of the Department of Preventive Medicine and Division of Cardiology at Northwestern University Feinberg School of Medicine, discuss the use of eze ...  Show more